Entering text into the input field will update the search result below

Takeda loses bid to overturn $9B damage award

Aug. 29, 2014 7:33 AM ETEli Lilly and Company (LLY) StockLLYBy: Douglas W. House, SA News Editor
  • U.S. District Court of the Western District of Louisiana Judge Rebecca Doherty rules that the label of Takeda Pharmaceuticals' diabetes drug Actos did not adequately warn patients about the increased cancer risk. The $9B punitive damages awarded by a U.S. jury will stand for the time being.
  • The company made a separate of the verdict in April. Legal observers do not believe that the full amount of the award will stand.
  • Eli Lilly (NYSE:LLY) co-promoted Actos from 1999 to 2006. It says that Takeda agreed to indemnify it for its losses and expenses in the matter under the terms of its agreement.

Recommended For You

More Trending News

About LLY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
LLY--
Eli Lilly and Company
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.